South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading ->
‘Planetary health’ describes how the limits of natural resources like clean air, water and food production shape our long-term health, with climate change as a “threat-multiplier” for future COVID-19 like crises. Experts at the Geneva Health Forum explored the links, ahead of next week’s launch of the 2020 Lancet Countdown Report on Health and Climate […] Continue reading ->
Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading ->
The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading ->
AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading ->
WHO on Friday issued formal guidelines recommending against the use of remdesivir for COVID-19 patients, based on a  lack of evidence that the antiviral drug, developed by Gilead, significantly improves patient outcomes. The recommendation followed publication of trial results on the drug in the The BMJ  involving more than 7,000 patients who had been hospitalized […] Continue reading ->
COVID-19 and non-communicable diseases (NCDs) are combining as a “syndemic” that reinforce each other and disproportionately impact the most vulnerable communities in every country during the pandemic period, said experts at a NCD Alliance panel on Thursday.  However, primary health care workers, particularly nurses, who are the backbone of routine NCD responses have been particularly […] Continue reading ->